Literature DB >> 11485672

Penicillium marneffei infection in patients with AIDS.

T Sirisanthana1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11485672      PMCID： PMC2631818          DOI： 10.3201/eid0707.017734

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


× No keyword cloud information.
  9 in total

1.  Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients.

Authors:  T Sirisanthana; K Supparatpinyo; J Perriens; K E Nelson
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

2.  Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand.

Authors:  S Chariyalertsak; T Sirisanthana; K Supparatpinyo; J Praparattanapan; K E Nelson
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

3.  Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome.

Authors:  M R Piehl; R L Kaplan; M H Haber
Journal:  Arch Pathol Lab Med       Date:  1988-12       Impact factor: 5.534

4.  Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a clue to the reservoir?

Authors:  S Chariyalertsak; T Sirisanthana; K Supparatpinyo; K E Nelson
Journal:  J Infect Dis       Date:  1996-06       Impact factor: 5.226

5.  A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus.

Authors:  K Supparatpinyo; J Perriens; K E Nelson; T Sirisanthana
Journal:  N Engl J Med       Date:  1998-12-10       Impact factor: 91.245

Review 6.  Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients.

Authors:  T Sirisanthana; K Supparatpinyo
Journal:  Int J Infect Dis       Date:  1998 Jul-Sep       Impact factor: 3.623

7.  Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.

Authors:  K Supparatpinyo; K E Nelson; W G Merz; B J Breslin; C R Cooper; C Kamwan; T Sirisanthana
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

8.  Disseminated Penicillium marneffei infection in southeast Asia.

Authors:  K Supparatpinyo; C Khamwan; V Baosoung; K E Nelson; T Sirisanthana
Journal:  Lancet       Date:  1994-07-09       Impact factor: 79.321

9.  Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei.

Authors:  S Chariyalertsak; P Vanittanakom; K E Nelson; T Sirisanthana; N Vanittanakom
Journal:  J Med Vet Mycol       Date:  1996 Mar-Apr
  9 in total
  3 in total

1.  Development and evaluation of rapid urinary antigen detection tests for diagnosis of penicilliosis marneffei.

Authors:  Varunee Desakorn; Andrew J H Simpson; Vanaporn Wuthiekanun; Duangjai Sahassananda; Adul Rajanuwong; Punnee Pitisuttithum; Paul A Howe; Michael D Smith; Nicholas J White
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

2.  Penicillium marneffei: a pathogen on our doorstep?

Authors:  Ferdinandos Skoulidis; Marina S Morgan; Kenneth M MacLeod
Journal:  J R Soc Med       Date:  2004-08       Impact factor: 18.000

3.  Disseminated talaromycosis complicated by recurrent gastrointestinal bleeding and hemorrhagic shock: a case report.

Authors:  Xiaoya Cui; Feifei Su; Hui Ye; Yi Jiang; Xiuxiu Guo
Journal:  BMC Infect Dis       Date:  2022-03-09       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.